Manufacturing Facility

Purpose Build Biological Plant In Pakistan

The Searle Biosciences (Pvt.) Limited subsidiary of The Searle company has acquired Nextar Pharma (Pvt) Limited for rDNA manufacturing with the help of technology from ICGEB (International Center Of Genetic Engineering & Biotechnology) Italy.

Specially designed to manufacture rDNA liquid Injectable State of the art infrastructure with validated compliance

Production machineries

Quality control equipment

Utilities

Validated cold storage and transportations up to the consumer

The plant is reviewed for FDA approval in 2016.

The first Pakistani plant is expected to get approval in 2019.